Literature DB >> 22895356

Sampling human indigenous saliva peptidome using a lollipop-like ultrafiltration probe: simplify and enhance peptide detection for clinical mass spectrometry.

Wenhong Zhu1, Richard L Gallo, Chun-Ming Huang.   

Abstract

Although human saliva proteome and peptidome have been revealed they were majorly identified from tryptic digests of saliva proteins. Identification of indigenous peptidome of human saliva without prior digestion with exogenous enzymes becomes imperative, since native peptides in human saliva provide potential values for diagnosing disease, predicting disease progression, and monitoring therapeutic efficacy. Appropriate sampling is a critical step for enhancement of identification of human indigenous saliva peptidome. Traditional methods of sampling human saliva involving centrifugation to remove debris may be too time-consuming to be applicable for clinical use. Furthermore, debris removal by centrifugation may be unable to clean most of the infected pathogens and remove the high abundance proteins that often hinder the identification of low abundance peptidome. Conventional proteomic approaches that primarily utilize two-dimensional gel electrophoresis (2-DE) gels in conjugation with in-gel digestion are capable of identifying many saliva proteins. However, this approach is generally not sufficiently sensitive to detect low abundance peptides/proteins. Liquid chromatography-Mass spectrometry (LC-MS) based proteomics is an alternative that can identify proteins without prior 2-DE separation. Although this approach provides higher sensitivity, it generally needs prior sample pre-fractionation and pre-digestion with trypsin, which makes it difficult for clinical use. To circumvent the hindrance in mass spectrometry due to sample preparation, we have developed a technique called capillary ultrafiltration (CUF) probes. Data from our laboratory demonstrated that the CUF probes are capable of capturing proteins in vivo from various microenvironments in animals in a dynamic and minimally invasive manner. No centrifugation is needed since a negative pressure is created by simply syringe withdrawing during sample collection. The CUF probes combined with LC-MS have successfully identified tryptic-digested proteins. In this study, we upgraded the ultrafiltration sampling technique by creating a lollipop-like ultrafiltration (LLUF) probe that can easily fit in the human oral cavity. The direct analysis by LC-MS without trypsin digestion showed that human saliva indigenously contains many peptide fragments derived from various proteins. Sampling saliva with LLUF probes avoided centrifugation but effectively removed many larger and high abundance proteins. Our mass spectrometric results illustrated that many low abundance peptides became detectable after filtering out larger proteins with LLUF probes. Detection of low abundance saliva peptides was independent of multiple-step sample separation with chromatography. For clinical application, the LLUF probes incorporated with LC-MS could potentially be used in the future to monitor disease progression from saliva.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895356      PMCID: PMC3476758          DOI: 10.3791/4108

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  38 in total

1.  A simplified monobuffer multidimensional chromatography for high-throughput proteome fractionation.

Authors:  L Guerrier; L Lomas; E Boschetti
Journal:  J Chromatogr A       Date:  2005-05-06       Impact factor: 4.759

2.  Pore architecture of diatom frustules: potential nanostructured membranes for molecular and particle separations.

Authors:  Dusan Losic; Gary Rosengarten; James G Mitchell; Nicolas H Voelcker
Journal:  J Nanosci Nanotechnol       Date:  2006-04

3.  Complete amino acid sequence of a basic proline-rich peptide, P-D, from human parotid saliva.

Authors:  E Saitoh; S Isemura; K Sanada
Journal:  J Biochem       Date:  1983-02       Impact factor: 3.387

4.  Possible release of an ArgGlyArgProGln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal streptococcus and actinomyces species.

Authors:  T Li; P Bratt; A P Jonsson; M Ryberg; I Johansson; W J Griffiths; T Bergman; N Strömberg
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

5.  Identification and characterization of a protease from Streptococcus oralis C104.

Authors:  C S Lo; C V Hughes
Journal:  Oral Microbiol Immunol       Date:  1996-06

6.  Gln-Gly cleavage: correlation between collision-induced dissociation and biological degradation.

Authors:  A P Jonsson; T Bergman; H Jörnvall; W J Griffiths; P Bratt; N Strömberg
Journal:  J Am Soc Mass Spectrom       Date:  2001-03       Impact factor: 3.109

Review 7.  Oral mucosal immunity and HIV infection: current status.

Authors:  S J Challacombe; S P Sweet
Journal:  Oral Dis       Date:  2002       Impact factor: 3.511

8.  Protein-Sequence Polymorphisms and Post-translational Modifications in Proteins from Human Saliva using Top-Down Fourier-transform Ion Cyclotron Resonance Mass Spectrometry.

Authors:  Julian P Whitelegge; Vlad Zabrouskov; Frederic Halgand; Puneet Souda; Sara Bassilian; Weihong Yan; Larry Wolinsky; Joseph A Loo; David T W Wong; Kym F Faull
Journal:  Int J Mass Spectrom       Date:  2007-12-01       Impact factor: 1.986

9.  Adhesion of Streptococcus mutans to salivary proteins in caries-free and caries-susceptible individuals.

Authors:  Pacífico Castro; Jairo A Tovar; Lorenza Jaramillo
Journal:  Acta Odontol Latinoam       Date:  2006

Review 10.  Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry.

Authors:  Jose L Luque-Garcia; Thomas A Neubert
Journal:  J Chromatogr A       Date:  2006-12-12       Impact factor: 4.759

View more
  1 in total

1.  Oral Biofilm Sampling for Microbiome Analysis in Healthy Children.

Authors:  Elisabeth Santigli; Martin Koller; Barbara Klug
Journal:  J Vis Exp       Date:  2017-12-31       Impact factor: 1.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.